245 related articles for article (PubMed ID: 35144669)
81. Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens.
Kitamura K; Nimura K; Ito R; Saga K; Inohara H; Kaneda Y
Sci Rep; 2020 Dec; 10(1):22138. PubMed ID: 33335126
[TBL] [Abstract][Full Text] [Related]
82. Evaluation and validation of HPV real-time PCR assay for the detection of HPV DNA in oral cytobrush and FFPE samples.
Harlé A; Guillet J; Thomas J; Sastre-Garau X; Rouyer M; Ramacci C; Gilson P; Dubois C; Dolivet G; Leroux A; Salleron J; Merlin JL
Sci Rep; 2018 Jul; 8(1):11313. PubMed ID: 30054550
[TBL] [Abstract][Full Text] [Related]
83. Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Bristol ML; James CD; Wang X; Fontan CT; Morgan IM
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188745
[TBL] [Abstract][Full Text] [Related]
84. Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.
Sitz J; Blanchet SA; Gameiro SF; Biquand E; Morgan TM; Galloy M; Dessapt J; Lavoie EG; Blondeau A; Smith BC; Mymryk JS; Moody CA; Fradet-Turcotte A
Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19552-19562. PubMed ID: 31501315
[TBL] [Abstract][Full Text] [Related]
85. Gene expression profiles in HPV-infected head and neck cancer.
Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
[TBL] [Abstract][Full Text] [Related]
86. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
87. Oncogenic E6 and/or E7 proteins drive proliferation and invasion of human papilloma virus‑positive head and neck squamous cell cancer through upregulation of Ror2 expression.
Avincsal MO; Kamizaki K; Jimbo N; Shinomiya H; Nibu KI; Nishita M; Minami Y
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080643
[TBL] [Abstract][Full Text] [Related]
88. Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer.
Heitmann J; Geeleher P; Zuo Z; Weichselbaum RR; Vokes EE; Fetscher S; Seiwert TY
Oral Oncol; 2014 Sep; 50(9):825-31. PubMed ID: 25017803
[TBL] [Abstract][Full Text] [Related]
89. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
Hoffmann M; Ihloff AS; Görögh T; Weise JB; Fazel A; Krams M; Rittgen W; Schwarz E; Kahn T
Int J Cancer; 2010 Oct; 127(7):1595-602. PubMed ID: 20091864
[TBL] [Abstract][Full Text] [Related]
90. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
91. Role of genetic variations of DNA damage response pathway genes and heat-shock proteins in increased head and neck cancer risk.
Mahjabeen I; Sheshe S; Shakoor T; Hussain MZ; Rizwan M; Mehmood A; Haris MS; Fazal F; Burki A; Kayani MA
Future Oncol; 2022 Oct; 18(31):3519-3535. PubMed ID: 36200797
[TBL] [Abstract][Full Text] [Related]
92. DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.
Papalouka C; Adamaki M; Batsaki P; Zoumpourlis P; Tsintarakis A; Goulielmaki M; Fortis SP; Baxevanis CN; Zoumpourlis V
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769087
[TBL] [Abstract][Full Text] [Related]
93. Human papillomavirus-driven head and neck cancers in Japan during 2008-2009 and 2018-2019: The BROADEN study.
Nibu KI; Oridate N; Saito Y; Roset M; Forés Maresma M; Cuadras D; Morais E; Roberts C; Chen YT; Spitzer J; Sato K; Saito I; Tazaki I; Clavero O; Schroeder L; Alemany L; Mehanna H; Mirghani H; Giuliano AR; Pavón MA; Waterboer T
Cancer Sci; 2024 Jun; ():. PubMed ID: 38847353
[TBL] [Abstract][Full Text] [Related]
94. HPV Associated Head and Neck Cancer.
Spence T; Bruce J; Yip KW; Liu FF
Cancers (Basel); 2016 Aug; 8(8):. PubMed ID: 27527216
[TBL] [Abstract][Full Text] [Related]
95. For Better or Worse: Modulation of the Host DNA Damage Response by Human Papillomavirus.
Studstill CJ; Moody CA
Annu Rev Virol; 2023 Sep; 10(1):325-345. PubMed ID: 37040798
[TBL] [Abstract][Full Text] [Related]
96. Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer.
Xiao C; Beitler JJ; Higgins KA; Wommack EC; Saba NF; Shin DM; Bruner DW; Miller AH; Cole S
Brain Behav Immun; 2018 Nov; 74():291-295. PubMed ID: 30217537
[TBL] [Abstract][Full Text] [Related]
97.
Das R; Kundu S; Laskar S; Choudhury Y; Ghosh SK
J Biomol Struct Dyn; 2023 Apr; 41(6):2090-2107. PubMed ID: 35037836
[TBL] [Abstract][Full Text] [Related]
98. Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.
Nilsson K; Wu C; Schwartz S
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895741
[TBL] [Abstract][Full Text] [Related]
99. Targeting Head and Neck Cancer by Vaccination.
Wang C; Dickie J; Sutavani RV; Pointer C; Thomas GJ; Savelyeva N
Front Immunol; 2018; 9():830. PubMed ID: 29740440
[TBL] [Abstract][Full Text] [Related]
100. Use of 3D Spheroid Models for the Assessment of RT Response in Head and Neck Cancer.
Wegge M; Dok R; Dubois LJ; Nuyts S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
